A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis

Published:2012-02 Issue:2 Volume:132 Page:304-314
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Gordon Kenneth B.,Langley Richard G.,Gottlieb Alice B.,Papp Kim A.,Krueger Gerald G.,Strober Bruce E.,Williams David A.,Gu Yihua,Valdes Joaquin M.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference30 articles.

1. The IL-23/Th17 axis in the immunopathogenesis of psoriasis;Di Cesare;J Invest Dermatol,2009

2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001

3. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features;Filipe-Santos;Semin Immunol,2006

4. Risk of myocardial infarction in patients with psoriasis;Gelfand;JAMA,2006

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased vesicular dynamics and nanoscale clustering of IL-2 after T cell activation;Biophysical Journal;2024-08

2. Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in Korea;Journal of Dermatological Treatment;2024-02-25

3. Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data;Frontiers in Immunology;2024-02-07

4. A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agents;Journal of Dermatological Treatment;2023-11-15

5. A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis;Frontiers in Immunology;2023-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3